Alterations in succinate dehydrogenase (SDH), tuberous sclerosis (TSC) and fructose-1,6-bisphosphatase 1 (FBP1) represent additional lesions that drive metabolic reprogramming in kidney cancer32. The gene discussed is SDHB; the disease is tuberous sclerosis.